MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 1501 to 1520 of 166,322 approvalsPage 76 of 8317

Gabapentin Capsules

Approval Number: 国药准字H20253339
Registration: Feb 8, 2025

Atomoxetine Hydrochloride Capsules

Approval Number: 国药准字H20253340
Registration: Feb 8, 2025

Fluorouracil Injection

Approval Number: 国药准字H20253343
Registration: Feb 8, 2025

Tafluprost Eye Drops

Approval Number: 国药准字H20253359
Registration: Feb 8, 2025

Cefpodoxime Proxetil Tablets

Approval Number: 国药准字H20253331
Registration: Feb 8, 2025

Lactulose Oral Solution

Approval Number: 国药准字H20253348
Registration: Feb 8, 2025

Roxadustat Capsules

Approval Number: 国药准字H20253333
Registration: Feb 8, 2025

Edoxaban Tosilate Tablets

Approval Number: 国药准字H20253357
Registration: Feb 8, 2025

Montelukast Sodium Chewable Tablets

Approval Number: 国药准字H20253342
Registration: Feb 8, 2025

Oxygen

Approval Number: 国药准字H20253337
Registration: Feb 8, 2025

Loxoprofen Sodium Cataplasms

Approval Number: 国药准字H20253334
Registration: Feb 8, 2025

Carbocysteine Oral Solution

Approval Number: 国药准字H20253350
Registration: Feb 8, 2025

Brentuximab Vedotin for Injection

Approval Number: 国药准字SJ20200008
Registration: Feb 7, 2025

Denosumab Injection

Approval Number: 国药准字SJ20200019
Registration: Feb 7, 2025

Dehydrocholic Acid Tablets

Approval Number: 国药准字H37022329
Registration: Feb 6, 2025

氢化可的松

Approval Number: 国药准字H37020355
Registration: Feb 6, 2025

Oryzanol Tablets

Approval Number: 国药准字H37020410
Registration: Feb 6, 2025

Piracetam Tablets

Approval Number: 国药准字H37020256
Registration: Feb 6, 2025

Rubidate Tablets

Approval Number: 国药准字H37023181
Registration: Feb 6, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.